Healing Abutments for Dental Implants

(Aharct Trial)

Not yet recruiting at 1 trial location
MD
LM
Overseen ByLuis Mezzomo, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Illinois at Chicago
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to evaluate whether an anatomical prefabricated healing abutment (AHA) improves tissue preservation and clinical outcomes following immediate implant placement after tooth extraction in adults. Although immediate implant placement is a well-established treatment for replacing missing teeth, healing can result in changes to the surrounding bone and soft tissues that may affect the esthetic appearance, function, and long-term stability of the implant-supported restoration. This study will compare an anatomical healing abutment, designed to mimic the natural tooth emergence profile and support peri-implant tissues during healing, with a conventional healing abutment. The primary objectives are to determine whether the AHA better preserves soft tissue contours and alveolar bone, improves implant positioning accuracy and tissue stability during healing, and differs from a conventional healing abutment in complications or adverse events. Eligible participants will be adults requiring extraction of a hopeless tooth in the posterior maxilla or mandible who are suitable candidates for immediate implant placement. Following tooth extraction and implant placement, participants will receive either an anatomical prefabricated healing abutment or a conventional healing abutment and will return for scheduled follow-up visits over approximately 12 months to assess healing, implant stability, and changes in the surrounding hard and soft tissues. Researchers will collect clinical measurements, digital intraoral scans, photographs, and radiographic images throughout the study. Additional research imaging will be used to generate three-dimensional models to measure tissue volume changes and implant position accuracy. Specialized software will compare changes between the two groups over time. Safety will be evaluated by monitoring participants for complications, discomfort, inflammation, implant-related problems, and other adverse events throughout follow-up. All procedures will be performed by trained dental professionals using established clinical protocols. The results may improve understanding of how healing abutment design influences tissue preservation after immediate implant placement and help optimize future implant therapy by supporting better functional, esthetic, and long-term outcomes.

Who Is on the Research Team?

LM

Luis Mezzomo, PhD

Principal Investigator

University of Illinois at Chicago

WP

Waldemar Polido, PhD

Principal Investigator

Indiana University

Are You a Good Fit for This Trial?

This trial is for adults who need a tooth removed in the back upper or lower jaw and are suitable for getting a dental implant placed right after extraction. Participants must be healthy enough for oral surgery and immediate implant placement.

Inclusion Criteria

I am between 20 and 75 years old.
ASA Classification I and II
Willing to perform tasks associated with the study and to attend all study visits
See 5 more

Exclusion Criteria

Self-reported pregnancy
I am currently taking medication to prevent bone loss.
I have cysts or tumors in the affected area.
See 11 more

What Are the Treatments Tested in This Trial?

Interventions

  • Anatomical Prefabricated Healing Abutment
  • Standard Healing Abutment for Dental Implants

Trial Overview

The study compares two types of healing abutments used after immediate dental implant placement: an anatomical prefabricated healing abutment (designed to better support gum and bone) versus a standard healing abutment. Participants are randomly assigned to one group, with follow-up over about 12 months.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: AHA GroupExperimental Treatment1 Intervention
Group II: Conventional Healing Abutment GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Illinois at Chicago

Lead Sponsor

Trials
653
Recruited
1,574,000+

Institut Straumann AG

Industry Sponsor

Trials
54
Recruited
2,700+

Indiana University

Collaborator

Trials
1,063
Recruited
1,182,000+

ITI International Team for Implantology, Switzerland

Collaborator

Trials
24
Recruited
1,000+